Medical CE & FDA Regulatory FAQ: Compliance Standards for Test Reports Recognized by European Notified Bodies

Overview

For B2B aesthetic clinic buyers and dermatologists, regulatory recognition of test reports is a make-or-break procurement criterion. European Notified Bodies do not accept every lab report at face value — they assess the testing laboratory’s accreditation scope, the applicable harmonized standards (EN 60601-1, EN 60601-1-2, EN 60825-1), and the completeness of the technical file. This FAQ answers the highest-intent compliance questions clinic owners ask before purchasing a medical aesthetic device, so you can verify documentation before you sign a PO.

Frequently Asked Questions

Q1: Are your test reports recognized by European Notified Bodies?

Yes — our test reports are issued by ISO/IEC 17025-accredited laboratories and are structured to be accepted by European Notified Bodies under Medical Device Regulation (EU) 2017/745. Recognition depends on three factors: the lab’s accreditation scope covering the exact test standard, traceable calibration of test equipment, and a complete technical file linking reports to the device’s risk analysis and clinical evaluation. We provide the full accreditation certificates and scope schedules alongside each report so your Notified Body can verify them directly.

Q2: Which harmonized standards are covered in your test reports?

Our reports typically cover EN 60601-1 (electrical safety), EN 60601-1-2 (EMC), EN 60825-1 (laser safety), EN 62304 (software lifecycle), and EN ISO 10993 series (biocompatibility) where applicable. Each report explicitly cites the standard edition and clause tested, which is exactly what a Notified Body reviewer checks first. We can also supply IEC 60601-1 editions for markets that still reference the older framework during transition periods.

Q3: Do your reports support Medical CE marking under EU MDR 2017/745?

Yes — our documentation package is designed to support Medical CE certification under EU MDR 2017/745, including Class IIa and IIb device pathways. The package includes the technical file index, GSPR checklist, risk management file per ISO 14971, and post-market surveillance plan templates. Your Notified Body remains the final decision-maker, but our reports are formatted to slot directly into their conformity assessment review without re-testing.

Q4: How do I verify that a test report is genuinely accredited and not self-declared?

Verify authenticity by cross-checking the issuing laboratory’s ISO/IEC 17025 accreditation number against the national accreditation body’s public database (e.g., DAkkS, UKAS, CNAS, A2LA). A genuine report will state the accreditation body, certificate number, and the specific scope under which the test was performed. We supply these verification details upfront and can arrange a direct confirmation letter from the laboratory if your compliance team requires it.

Q5: Are your test reports accepted for FDA 510(k) submissions as well?

Yes — our electrical safety, EMC, and laser safety reports are formatted to support FDA 510(k) submissions and align with recognized consensus standards. For the US pathway, reports must reference the FDA-recognized versions of IEC 60601-1 and IEC 60825-1, and we confirm edition alignment before shipment. We also provide a standards cross-reference sheet mapping each report to the corresponding FDA recognition number.

Q6: What documentation do you provide for ISO 13485 audits and Notified Body technical file reviews?

We provide an audit-ready documentation bundle including the ISO 13485 certificate, test reports with accreditation evidence, risk management file, label and IFU artwork, and a declaration of conformity template. This bundle is structured to match the technical documentation requirements of MDR Annex II and Annex III. For clinic buyers undergoing their own ISO 13485 or local regulator audits, we supply a documentation index so every file can be located in minutes.

Q7: Can you provide additional or re-tested reports if my Notified Body requests clarification?

Yes — we support post-sales regulatory follow-up, including clarification letters, additional test samples, and re-testing at accredited laboratories if your Notified Body raises a specific query. Typical turnaround for clarification letters is 5-10 business days, while re-testing depends on the standard and lab queue. We assign a named regulatory contact to your account so queries are tracked and answered without delays to your certification timeline.

Q8: Are the test reports valid across all EU member states and other regulated markets?

Yes — reports issued under ISO/IEC 17025 accreditation and referencing harmonized EN standards are recognized across all EU member states through the MDR framework, and are widely accepted in the UK (UKCA), Switzerland, and other MDR-aligned markets. For markets with local registration requirements (e.g., Brazil ANVISA, Japan PMDA), we provide the underlying reports plus translation support. Always confirm the applicable standard edition with your local regulator, as transitional provisions can vary by country.